Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Selecta Biosciences' Dr. Carsten Brunn on Gene Therapy with AAV Vectors

    Selecta Biosciences' Dr. Carsten Brunn on Gene Therapy with AAV Vectors

    FromCell & Gene: The Podcast

    Start listeningView podcast show

    Selecta Biosciences' Dr. Carsten Brunn on Gene Therapy with AAV Vectors

    FromCell & Gene: The Podcast

    ratings:
    Length:
    21 minutes
    Released:
    Feb 3, 2022
    Format:
    Podcast episode

    Description

    Selecta Biosciences' President and CEO Dr. Carsten Brunn details the company's ImmTOR platform, which can mitigate unwanted immune responses that cause immune-related toxicities that impose significant treatment challenges with current therapies.
    Released:
    Feb 3, 2022
    Format:
    Podcast episode

    Titles in the series (76)

    Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.